| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | mRNA binding | CIRBP DDX17 RBMXL3 FXR2 NUP98 RBM14 RBM5 RNF40 TAF15 HNRNPA1L2 FUS YTHDF2 | 4.05e-06 | 694 | 69 | 12 | GO:0003729 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | GRIP1 NEFL DDX17 TCF20 HIPK1 NUP98 DVL2 RBM14 EWSR1 TAF15 FUS ZMIZ1 ATP1B2 MED12 YTHDF2 | 7.73e-06 | 1160 | 69 | 15 | GO:0030674 |
| GeneOntologyMolecularFunction | transcription coregulator activity | 2.20e-05 | 562 | 69 | 10 | GO:0003712 | |
| GeneOntologyMolecularFunction | mRNA 3'-UTR binding | 4.64e-05 | 276 | 69 | 7 | GO:0003730 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | GRIP1 NEFL DDX17 TCF20 HIPK1 NUP98 DVL2 RBM14 EWSR1 TAF15 FUS ZMIZ1 ATP1B2 MED12 YTHDF2 | 4.84e-05 | 1356 | 69 | 15 | GO:0060090 |
| GeneOntologyMolecularFunction | transcription coactivator activity | 8.34e-05 | 303 | 69 | 7 | GO:0003713 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 7.45e-04 | 118 | 69 | 4 | GO:0003774 | |
| GeneOntologyMolecularFunction | ionotropic glutamate receptor binding | 7.73e-04 | 52 | 69 | 3 | GO:0035255 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 7.93e-04 | 120 | 69 | 4 | GO:0008013 | |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 1.23e-03 | 61 | 69 | 3 | GO:0030374 | |
| GeneOntologyMolecularFunction | plus-end-directed microtubule motor activity | 1.55e-03 | 17 | 69 | 2 | GO:0008574 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.83e-03 | 70 | 69 | 3 | GO:0003777 | |
| GeneOntologyBiologicalProcess | RNA splicing | CIRBP DDX17 RBMXL3 NUP98 RBM14 RBM5 FAM98A TAF15 HNRNPA1L2 FUS HNRNPUL1 | 8.12e-07 | 502 | 69 | 11 | GO:0008380 |
| GeneOntologyBiologicalProcess | cochlea development | 1.86e-06 | 61 | 69 | 5 | GO:0090102 | |
| GeneOntologyBiologicalProcess | embryonic organ morphogenesis | 2.49e-06 | 351 | 69 | 9 | GO:0048562 | |
| GeneOntologyBiologicalProcess | cochlea morphogenesis | 2.56e-06 | 29 | 69 | 4 | GO:0090103 | |
| GeneOntologyBiologicalProcess | inner ear morphogenesis | 4.62e-06 | 129 | 69 | 6 | GO:0042472 | |
| GeneOntologyBiologicalProcess | mRNA metabolic process | CIRBP DDX17 RBMXL3 FXR2 NUP98 RBM14 RBM5 TAF15 HNRNPA1L2 FUS HNRNPUL1 CREB1 YTHDF2 | 9.32e-06 | 917 | 69 | 13 | GO:0016071 |
| GeneOntologyBiologicalProcess | ear morphogenesis | 1.28e-05 | 154 | 69 | 6 | GO:0042471 | |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | 1.62e-05 | 443 | 69 | 9 | GO:1903311 | |
| GeneOntologyBiologicalProcess | embryonic organ development | 1.64e-05 | 561 | 69 | 10 | GO:0048568 | |
| GeneOntologyBiologicalProcess | sensory organ morphogenesis | 1.86e-05 | 343 | 69 | 8 | GO:0090596 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | SOX9 OTX2 ZEB1 FOXN4 SOBP HIPK1 DVL2 RBM14 EYA1 MED12 YTHDF2 | 2.29e-05 | 713 | 69 | 11 | GO:0048598 |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | 2.53e-05 | 358 | 69 | 8 | GO:0000398 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 2.53e-05 | 358 | 69 | 8 | GO:0000377 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | 2.74e-05 | 362 | 69 | 8 | GO:0000375 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | SOX9 MET OTX2 ZEB1 DDX17 TCF20 EBF3 FOXN4 DVL2 RBM14 RNF40 EYA1 ZMIZ1 CREB1 MED12 | 4.44e-05 | 1390 | 69 | 15 | GO:0045944 |
| GeneOntologyBiologicalProcess | embryo development | SOX9 OTX2 ZEB1 FOXN4 SOBP HIPK1 LPA DVL2 RBM14 DLG3 EYA1 ZMIZ1 FOXI3 MED12 YTHDF2 | 6.50e-05 | 1437 | 69 | 15 | GO:0009790 |
| GeneOntologyBiologicalProcess | regulation of RNA splicing | 6.73e-05 | 207 | 69 | 6 | GO:0043484 | |
| GeneOntologyBiologicalProcess | retrograde axonal transport | 6.90e-05 | 24 | 69 | 3 | GO:0008090 | |
| GeneOntologyBiologicalProcess | regulation of mRNA splicing, via spliceosome | 7.22e-05 | 129 | 69 | 5 | GO:0048024 | |
| GeneOntologyBiologicalProcess | epithelium development | SOX9 MET CDSN OTX2 ZEB1 FOXN4 LORICRIN DVL2 DLG3 EYA1 HRNR FLG2 FOXI3 CREB1 MED12 | 8.34e-05 | 1469 | 69 | 15 | GO:0060429 |
| GeneOntologyBiologicalProcess | alternative mRNA splicing, via spliceosome | 1.43e-04 | 79 | 69 | 4 | GO:0000380 | |
| GeneOntologyBiologicalProcess | retrograde neuronal dense core vesicle transport | 1.64e-04 | 6 | 69 | 2 | GO:1990049 | |
| GeneOntologyBiologicalProcess | regulation of mRNA processing | 1.87e-04 | 158 | 69 | 5 | GO:0050684 | |
| GeneOntologyBiologicalProcess | inner ear development | 2.02e-04 | 253 | 69 | 6 | GO:0048839 | |
| GeneOntologyBiologicalProcess | anterograde dendritic transport of neurotransmitter receptor complex | 2.29e-04 | 7 | 69 | 2 | GO:0098971 | |
| GeneOntologyBiologicalProcess | skin epidermis development | 2.36e-04 | 166 | 69 | 5 | GO:0098773 | |
| GeneOntologyBiologicalProcess | neuron fate commitment | 2.46e-04 | 91 | 69 | 4 | GO:0048663 | |
| GeneOntologyBiologicalProcess | skin development | 2.46e-04 | 373 | 69 | 7 | GO:0043588 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | 2.47e-04 | 931 | 69 | 11 | GO:0098916 | |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | 2.47e-04 | 931 | 69 | 11 | GO:0007268 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | SOX9 MET CDSN OTX2 ZEB1 FOXN4 SOBP HIPK1 DVL2 EYA1 ZMIZ1 FOXI3 MED12 | 2.60e-04 | 1269 | 69 | 13 | GO:0009887 |
| GeneOntologyBiologicalProcess | positive regulation of gene expression | CIRBP SOX9 MET RBMXL3 FXR2 NUP98 RBM14 FAM98A TAF15 HNRNPA1L2 FUS CREB1 PGC YTHDF2 | 2.61e-04 | 1446 | 69 | 14 | GO:0010628 |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | 2.66e-04 | 939 | 69 | 11 | GO:0099537 | |
| GeneOntologyBiologicalProcess | delamination | 3.05e-04 | 8 | 69 | 2 | GO:0060232 | |
| GeneOntologyBiologicalProcess | positive regulation of neuron projection arborization | 3.05e-04 | 8 | 69 | 2 | GO:0150012 | |
| GeneOntologyBiologicalProcess | establishment of skin barrier | 3.49e-04 | 41 | 69 | 3 | GO:0061436 | |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | 3.52e-04 | 663 | 69 | 9 | GO:0050804 | |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | 3.55e-04 | 664 | 69 | 9 | GO:0099177 | |
| GeneOntologyBiologicalProcess | receptor localization to synapse | 3.67e-04 | 101 | 69 | 4 | GO:0097120 | |
| GeneOntologyBiologicalProcess | synaptic signaling | 3.70e-04 | 976 | 69 | 11 | GO:0099536 | |
| GeneOntologyBiologicalProcess | neuron fate specification | 3.75e-04 | 42 | 69 | 3 | GO:0048665 | |
| GeneOntologyBiologicalProcess | lung cell differentiation | 3.75e-04 | 42 | 69 | 3 | GO:0060479 | |
| GeneOntologyBiologicalProcess | lung epithelial cell differentiation | 3.75e-04 | 42 | 69 | 3 | GO:0060487 | |
| GeneOntologyBiologicalProcess | ear development | 3.82e-04 | 285 | 69 | 6 | GO:0043583 | |
| GeneOntologyBiologicalProcess | anterograde axonal protein transport | 3.91e-04 | 9 | 69 | 2 | GO:0099641 | |
| GeneOntologyBiologicalProcess | semicircular canal morphogenesis | 3.91e-04 | 9 | 69 | 2 | GO:0048752 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA splicing, via spliceosome | 4.30e-04 | 44 | 69 | 3 | GO:0048026 | |
| GeneOntologyBiologicalProcess | type I pneumocyte differentiation | 4.88e-04 | 10 | 69 | 2 | GO:0060509 | |
| GeneOntologyBiologicalProcess | mRNA processing | 4.92e-04 | 551 | 69 | 8 | GO:0006397 | |
| GeneOntologyBiologicalProcess | central nervous system development | SOX9 MET NEFL OTX2 ZEB1 FXR2 FOXN4 BRINP1 ZMIZ1 ATP1B2 CREB1 MED12 | 5.63e-04 | 1197 | 69 | 12 | GO:0007417 |
| GeneOntologyBiologicalProcess | positive regulation of mRNA processing | 5.91e-04 | 49 | 69 | 3 | GO:0050685 | |
| GeneOntologyBiologicalProcess | axo-dendritic protein transport | 5.95e-04 | 11 | 69 | 2 | GO:0099640 | |
| GeneOntologyBiologicalProcess | protein localization to presynapse | 5.95e-04 | 11 | 69 | 2 | GO:1905383 | |
| GeneOntologyBiologicalProcess | semicircular canal development | 5.95e-04 | 11 | 69 | 2 | GO:0060872 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | 6.02e-04 | 870 | 69 | 10 | GO:0030855 | |
| GeneOntologyBiologicalProcess | eye morphogenesis | 6.06e-04 | 204 | 69 | 5 | GO:0048592 | |
| GeneOntologyBiologicalProcess | otic vesicle morphogenesis | 7.12e-04 | 12 | 69 | 2 | GO:0071600 | |
| GeneOntologyBiologicalProcess | anterograde dendritic transport | 7.12e-04 | 12 | 69 | 2 | GO:0098937 | |
| GeneOntologyBiologicalProcess | dense core granule cytoskeletal transport | 7.12e-04 | 12 | 69 | 2 | GO:0099519 | |
| GeneOntologyBiologicalProcess | cell fate specification | 7.72e-04 | 123 | 69 | 4 | GO:0001708 | |
| GeneOntologyBiologicalProcess | anterograde axonal transport | 8.30e-04 | 55 | 69 | 3 | GO:0008089 | |
| GeneOntologyBiologicalProcess | epidermis development | 8.70e-04 | 461 | 69 | 7 | GO:0008544 | |
| GeneOntologyBiologicalProcess | head development | 9.18e-04 | 919 | 69 | 10 | GO:0060322 | |
| GeneOntologyBiologicalProcess | dense core granule transport | 9.78e-04 | 14 | 69 | 2 | GO:1901950 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | 1.05e-03 | 619 | 69 | 8 | GO:0002009 | |
| GeneOntologyBiologicalProcess | lung epithelium development | 1.12e-03 | 61 | 69 | 3 | GO:0060428 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection arborization | 1.13e-03 | 15 | 69 | 2 | GO:0150011 | |
| GeneOntologyBiologicalProcess | forebrain development | 1.22e-03 | 489 | 69 | 7 | GO:0030900 | |
| GeneOntologyBiologicalProcess | positive regulation of RNA splicing | 1.23e-03 | 63 | 69 | 3 | GO:0033120 | |
| GeneOntologyBiologicalProcess | microtubule-based protein transport | 1.45e-03 | 17 | 69 | 2 | GO:0099118 | |
| GeneOntologyBiologicalProcess | protein transport along microtubule | 1.45e-03 | 17 | 69 | 2 | GO:0098840 | |
| GeneOntologyBiologicalProcess | otic vesicle development | 1.45e-03 | 17 | 69 | 2 | GO:0071599 | |
| GeneOntologyBiologicalProcess | protein localization to cell junction | 1.53e-03 | 148 | 69 | 4 | GO:1902414 | |
| GeneOntologyBiologicalProcess | cytoplasm organization | 1.63e-03 | 18 | 69 | 2 | GO:0007028 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA metabolic process | 1.75e-03 | 259 | 69 | 5 | GO:1903313 | |
| GeneOntologyBiologicalProcess | dendritic transport | 1.82e-03 | 19 | 69 | 2 | GO:0098935 | |
| GeneOntologyBiologicalProcess | pattern specification process | 1.86e-03 | 526 | 69 | 7 | GO:0007389 | |
| GeneOntologyBiologicalProcess | cellular response to retinoic acid | 1.88e-03 | 73 | 69 | 3 | GO:0071300 | |
| GeneOntologyCellularComponent | cornified envelope | 7.55e-05 | 69 | 68 | 4 | GO:0001533 | |
| GeneOntologyCellularComponent | keratohyalin granule | 1.04e-04 | 5 | 68 | 2 | GO:0036457 | |
| GeneOntologyCellularComponent | postsynaptic cytosol | 4.24e-04 | 45 | 68 | 3 | GO:0099524 | |
| GeneOntologyCellularComponent | growth cone | 1.21e-03 | 245 | 68 | 5 | GO:0030426 | |
| GeneOntologyCellularComponent | dendritic spine head | 1.21e-03 | 16 | 68 | 2 | GO:0044327 | |
| GeneOntologyCellularComponent | ciliary rootlet | 1.21e-03 | 16 | 68 | 2 | GO:0035253 | |
| GeneOntologyCellularComponent | site of polarized growth | 1.40e-03 | 253 | 68 | 5 | GO:0030427 | |
| GeneOntologyCellularComponent | axon cytoplasm | 1.42e-03 | 68 | 68 | 3 | GO:1904115 | |
| GeneOntologyCellularComponent | cytosolic region | 1.54e-03 | 70 | 68 | 3 | GO:0099522 | |
| GeneOntologyCellularComponent | dendrite | 1.78e-03 | 858 | 68 | 9 | GO:0030425 | |
| GeneOntologyCellularComponent | dendritic tree | 1.81e-03 | 860 | 68 | 9 | GO:0097447 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 1.83e-03 | 269 | 68 | 5 | GO:0036464 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 2.43e-03 | 287 | 68 | 5 | GO:0035770 | |
| GeneOntologyCellularComponent | nuclear body | 2.52e-03 | 903 | 68 | 9 | GO:0016604 | |
| MousePheno | abnormal pterygoid process morphology | 1.62e-06 | 21 | 59 | 4 | MP:0004452 | |
| MousePheno | neonatal lethality, complete penetrance | 1.21e-05 | 534 | 59 | 11 | MP:0011087 | |
| MousePheno | abnormal pterygoid bone morphology | 1.53e-05 | 12 | 59 | 3 | MP:0004453 | |
| MousePheno | abnormal Meckel's cartilage morphology | 2.58e-05 | 41 | 59 | 4 | MP:0005587 | |
| MousePheno | perinatal lethality, complete penetrance | SOX9 MET CDSN OTX2 ZEB1 EBF3 NUP98 HNRNPA1L2 KIF5A FUS EYA1 FOXI3 | 3.42e-05 | 712 | 59 | 12 | MP:0011089 |
| MousePheno | abnormal cranial cartilage morphology | 5.70e-05 | 50 | 59 | 4 | MP:0030464 | |
| MousePheno | circling | 1.32e-04 | 117 | 59 | 5 | MP:0001394 | |
| MousePheno | abnormal incus morphology | 1.36e-04 | 24 | 59 | 3 | MP:0005106 | |
| MousePheno | absent inner ear | 1.74e-04 | 5 | 59 | 2 | MP:0006285 | |
| MousePheno | absent pharyngeal arches | 1.94e-04 | 27 | 59 | 3 | MP:0003874 | |
| MousePheno | perinatal lethality | GRIP1 SOX9 MET CDSN OTX2 ZEB1 EBF3 NUP98 DVL2 HNRNPA1L2 KIF5A FUS EYA1 FOXI3 | 1.97e-04 | 1130 | 59 | 14 | MP:0002081 |
| MousePheno | decreased posterior semicircular canal size | 2.60e-04 | 6 | 59 | 2 | MP:0003164 | |
| MousePheno | stereotypic behavior | 2.75e-04 | 214 | 59 | 6 | MP:0001408 | |
| MousePheno | abnormal endolymphatic duct morphology | 2.95e-04 | 31 | 59 | 3 | MP:0006011 | |
| MousePheno | rib fusion | 3.23e-04 | 78 | 59 | 4 | MP:0000154 | |
| MousePheno | abnormal maxilla morphology | 3.46e-04 | 144 | 59 | 5 | MP:0000455 | |
| MousePheno | non-midline cleft palate | 3.63e-04 | 7 | 59 | 2 | MP:0021209 | |
| MousePheno | bilateral cleft palate | 3.63e-04 | 7 | 59 | 2 | MP:0021210 | |
| MousePheno | decreased lateral semicircular canal size | 3.63e-04 | 7 | 59 | 2 | MP:0003162 | |
| MousePheno | abnormal malleus morphology | 3.89e-04 | 34 | 59 | 3 | MP:0000029 | |
| MousePheno | abnormal eyelid morphology | 4.33e-04 | 233 | 59 | 6 | MP:0001340 | |
| MousePheno | neonatal lethality | 4.46e-04 | 799 | 59 | 11 | MP:0002058 | |
| MousePheno | abnormal cornea stroma morphology | 5.42e-04 | 38 | 59 | 3 | MP:0005300 | |
| MousePheno | abnormal pharyngeal pouch morphology | 6.19e-04 | 9 | 59 | 2 | MP:0006031 | |
| MousePheno | absent maxilla | 6.19e-04 | 9 | 59 | 2 | MP:0004539 | |
| MousePheno | abnormal larynx morphology | 6.31e-04 | 40 | 59 | 3 | MP:0002249 | |
| MousePheno | abnormal sphenoid bone morphology | 6.84e-04 | 95 | 59 | 4 | MP:0000104 | |
| MousePheno | abnormal cornea epithelium morphology | 7.29e-04 | 42 | 59 | 3 | MP:0006000 | |
| MousePheno | absent outer ear | 7.71e-04 | 10 | 59 | 2 | MP:0005579 | |
| MousePheno | abnormal ischium morphology | 7.71e-04 | 10 | 59 | 2 | MP:0004507 | |
| Domain | - | 2.59e-08 | 10 | 64 | 4 | 4.10.1060.10 | |
| Domain | RRM_1 | 5.36e-07 | 208 | 64 | 8 | PF00076 | |
| Domain | RRM | 7.39e-07 | 217 | 64 | 8 | SM00360 | |
| Domain | zf-RanBP | 8.76e-07 | 22 | 64 | 4 | PF00641 | |
| Domain | RRM_dom | 1.04e-06 | 227 | 64 | 8 | IPR000504 | |
| Domain | ZnF_RBZ | 1.06e-06 | 23 | 64 | 4 | SM00547 | |
| Domain | ZF_RANBP2_2 | 1.06e-06 | 23 | 64 | 4 | PS50199 | |
| Domain | RRM | 1.14e-06 | 230 | 64 | 8 | PS50102 | |
| Domain | ZF_RANBP2_1 | 1.27e-06 | 24 | 64 | 4 | PS01358 | |
| Domain | Znf_RanBP2 | 1.50e-06 | 25 | 64 | 4 | IPR001876 | |
| Domain | Nucleotide-bd_a/b_plait | 2.70e-06 | 258 | 64 | 8 | IPR012677 | |
| Domain | - | 1.96e-05 | 244 | 64 | 7 | 3.30.70.330 | |
| Domain | Acyl-CoA-binding_protein | 3.19e-04 | 8 | 64 | 2 | IPR000582 | |
| Domain | Kinesin_motor_CS | 3.73e-04 | 41 | 64 | 3 | IPR019821 | |
| Domain | KINESIN_MOTOR_1 | 4.60e-04 | 44 | 64 | 3 | PS00411 | |
| Domain | - | 4.60e-04 | 44 | 64 | 3 | 3.40.850.10 | |
| Domain | Kinesin_motor_dom | 4.60e-04 | 44 | 64 | 3 | IPR001752 | |
| Domain | Kinesin | 4.60e-04 | 44 | 64 | 3 | PF00225 | |
| Domain | KINESIN_MOTOR_2 | 4.60e-04 | 44 | 64 | 3 | PS50067 | |
| Domain | KISc | 4.60e-04 | 44 | 64 | 3 | SM00129 | |
| Domain | S100_CABP | 3.84e-03 | 27 | 64 | 2 | PS00303 | |
| Domain | IPT | 3.84e-03 | 27 | 64 | 2 | SM00429 | |
| Domain | MARVEL | 3.84e-03 | 27 | 64 | 2 | PF01284 | |
| Domain | S_100 | 3.84e-03 | 27 | 64 | 2 | PF01023 | |
| Domain | S100_Ca-bd_sub | 4.13e-03 | 28 | 64 | 2 | IPR013787 | |
| Domain | S100/CaBP-9k_CS | 4.13e-03 | 28 | 64 | 2 | IPR001751 | |
| Domain | Marvel | 4.13e-03 | 28 | 64 | 2 | IPR008253 | |
| Domain | MARVEL | 4.13e-03 | 28 | 64 | 2 | PS51225 | |
| Domain | S_100 | 4.13e-03 | 28 | 64 | 2 | SM01394 | |
| Domain | TIG | 5.04e-03 | 31 | 64 | 2 | PF01833 | |
| Domain | IPT | 5.37e-03 | 32 | 64 | 2 | IPR002909 | |
| Domain | P-loop_NTPase | 8.16e-03 | 848 | 64 | 8 | IPR027417 | |
| Domain | Kinesin-like_fam | 9.54e-03 | 43 | 64 | 2 | IPR027640 | |
| Pathway | WP_MRNA_PROCESSING | 3.51e-05 | 451 | 52 | 9 | MM15946 | |
| Pathway | WP_MIR222_IN_EXERCISEINDUCED_CARDIAC_GROWTH | 1.33e-04 | 5 | 52 | 2 | MM15988 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_NMDA_RECEPTOR_MEDIATED_ACTIVATION_OF_RAS_SIGNALING | 1.45e-04 | 28 | 52 | 3 | M837 | |
| Pathway | REACTOME_LEISHMANIA_INFECTION | 1.47e-04 | 219 | 52 | 6 | M29836 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 2.85e-04 | 35 | 52 | 3 | MM15109 | |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | DDX17 AKAP8 FXR2 RBM14 HELZ EWSR1 FAM98A BRINP1 HNRNPA1L2 FUS HNRNPUL1 MED12 YTHDF2 | 6.67e-12 | 462 | 69 | 13 | 31138677 |
| Pubmed | Interactome of vertebrate GAF/ThPOK reveals its diverse functions in gene regulation and DNA repair. | DDX17 TCF20 FXR2 MYO10 RBM14 EWSR1 KIF5A FUS HNRNPUL1 CREB1 YTHDF2 | 3.95e-11 | 321 | 69 | 11 | 32098917 |
| Pubmed | DDX17 AKAP8 RBM14 EWSR1 FAM98A FUS HNRNPUL1 HRNR FLG2 YTHDF2 | 1.06e-10 | 260 | 69 | 10 | 36199071 | |
| Pubmed | NEFL DDX17 AKAP8 RBM14 RBM5 EWSR1 FAM98A TAF15 KIF5B FUS HNRNPUL1 YTHDF2 | 8.62e-10 | 551 | 69 | 12 | 34728620 | |
| Pubmed | CIRBP GRIP1 DDX17 AKAP8 FXR2 MYO10 RBM14 RBM5 EWSR1 FAM98A TAF15 HNRNPA1L2 YTHDF2 | 1.61e-09 | 723 | 69 | 13 | 34133714 | |
| Pubmed | 1.69e-09 | 346 | 69 | 10 | 25324306 | ||
| Pubmed | CIRBP RBMXL3 FXR2 NUP98 RBM14 RBM5 EWSR1 TAF15 HNRNPA1L2 FUS | 1.73e-09 | 347 | 69 | 10 | 16033648 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | HMBOX1 DDX17 AKAP8 FXR2 RBM14 RBM5 EWSR1 FAM98A TAF15 FUS HRNR FLG2 | 2.46e-09 | 605 | 69 | 12 | 28977666 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | CIRBP NEFL CDSN DDX17 TCF20 AKAP8 EBF3 RBM14 RBM5 EWSR1 TAF15 HNRNPUL1 HRNR FLG2 MED12 | 2.65e-09 | 1082 | 69 | 15 | 38697112 |
| Pubmed | 4.63e-09 | 11 | 69 | 4 | 33469008 | ||
| Pubmed | NEFL TCF20 FXR2 NUP98 HELZ EWSR1 TAF15 KIF5B FUS HNRNPUL1 MED12 USP47 | 5.77e-09 | 653 | 69 | 12 | 22586326 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | CIRBP DDX17 AKAP8 FXR2 RBM14 RBM5 HELZ EWSR1 FAM98A TAF15 FUS HNRNPUL1 YTHDF2 | 6.00e-09 | 807 | 69 | 13 | 22681889 |
| Pubmed | 7.47e-09 | 3 | 69 | 3 | 18620564 | ||
| Pubmed | mRNA and protein levels of FUS, EWSR1, and TAF15 are upregulated in liposarcoma. | 7.47e-09 | 3 | 69 | 3 | 21344536 | |
| Pubmed | Aggregation of FET Proteins as a Pathological Change in Amyotrophic Lateral Sclerosis. | 7.47e-09 | 3 | 69 | 3 | 27311318 | |
| Pubmed | 7.47e-09 | 3 | 69 | 3 | 27903134 | ||
| Pubmed | 7.47e-09 | 3 | 69 | 3 | 23049996 | ||
| Pubmed | 7.47e-09 | 3 | 69 | 3 | 23975937 | ||
| Pubmed | 7.47e-09 | 3 | 69 | 3 | 21856723 | ||
| Pubmed | 7.47e-09 | 3 | 69 | 3 | 27415968 | ||
| Pubmed | Characterization of a new brain-specific isoform of the EWS oncoprotein. | 7.47e-09 | 3 | 69 | 3 | 11422378 | |
| Pubmed | DDX17 AKAP8 FXR2 RBM14 EWSR1 FAM98A TAF15 FUS HNRNPUL1 USP47 | 1.09e-08 | 421 | 69 | 10 | 34650049 | |
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | 1.33e-08 | 430 | 69 | 10 | 38172120 | |
| Pubmed | CIRBP HMBOX1 SOX9 ZEB1 TCF20 AKAP8 SOBP NUP98 HELZ EWSR1 ZMIZ1 HNRNPUL1 HRNR FLG2 CREB1 YTHDF2 | 1.48e-08 | 1429 | 69 | 16 | 35140242 | |
| Pubmed | 2.18e-08 | 453 | 69 | 10 | 29656893 | ||
| Pubmed | ARIH2 Is a Vif-Dependent Regulator of CUL5-Mediated APOBEC3G Degradation in HIV Infection. | 2.24e-08 | 336 | 69 | 9 | 31253590 | |
| Pubmed | 2.38e-08 | 153 | 69 | 7 | 28225217 | ||
| Pubmed | 2.99e-08 | 4 | 69 | 3 | 28453628 | ||
| Pubmed | Glutamate-receptor-interacting protein GRIP1 directly steers kinesin to dendrites. | 2.99e-08 | 4 | 69 | 3 | 11986669 | |
| Pubmed | The neurodegenerative diseases ALS and SMA are linked at the molecular level via the ASC-1 complex. | 2.99e-08 | 4 | 69 | 3 | 30398641 | |
| Pubmed | 2.99e-08 | 4 | 69 | 3 | 9660765 | ||
| Pubmed | A HIV-1 Tat mutant protein disrupts HIV-1 Rev function by targeting the DEAD-box RNA helicase DDX1. | 3.05e-08 | 45 | 69 | 5 | 25496916 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 3.26e-08 | 351 | 69 | 9 | 38297188 | |
| Pubmed | ARMC5 is part of an RPB1-specific ubiquitin ligase implicated in adrenal hyperplasia. | 4.18e-08 | 166 | 69 | 7 | 35687106 | |
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 4.65e-08 | 258 | 69 | 8 | 37794589 | |
| Pubmed | NEFL ZEB1 TCF20 AKAP8 FXR2 EBF3 DVL2 DLG3 EWSR1 TAF15 KIF5A KIF5B FUS | 4.78e-08 | 963 | 69 | 13 | 28671696 | |
| Pubmed | CIRBP DDX17 RBMXL3 RBM14 EWSR1 FAM98A TAF15 HNRNPA1L2 KIF5A KIF5B FUS HNRNPUL1 HRNR YTHDF2 | 5.06e-08 | 1153 | 69 | 14 | 29845934 | |
| Pubmed | DDX17 AKAP8 FXR2 NUP98 RBM14 HELZ EWSR1 TAF15 FUS HNRNPUL1 YTHDF2 | 6.59e-08 | 655 | 69 | 11 | 35819319 | |
| Pubmed | 7.39e-08 | 274 | 69 | 8 | 34244482 | ||
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | DDX17 AKAP8 FXR2 RBM14 HELZ EWSR1 FAM98A TAF15 FUS HNRNPUL1 YTHDF2 | 9.33e-08 | 678 | 69 | 11 | 30209976 |
| Pubmed | 9.45e-08 | 187 | 69 | 7 | 29777862 | ||
| Pubmed | Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. | 1.49e-07 | 6 | 69 | 3 | 18509338 | |
| Pubmed | 1.49e-07 | 6 | 69 | 3 | 30354839 | ||
| Pubmed | 1.65e-07 | 122 | 69 | 6 | 29530978 | ||
| Pubmed | 2.70e-07 | 69 | 69 | 5 | 32238831 | ||
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 3.05e-07 | 457 | 69 | 9 | 32344865 | |
| Pubmed | 3.13e-07 | 136 | 69 | 6 | 21280222 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | DDX17 TCF20 NUP98 RBM14 EWSR1 FAM98A TAF15 HNRNPA1L2 FUS HNRNPUL1 CREB1 YTHDF2 | 3.55e-07 | 954 | 69 | 12 | 36373674 |
| Pubmed | MET DDX17 AKAP8 NUP98 RBM14 RBM5 DLG3 TAF15 HNRNPUL1 HRNR FLG2 | 3.62e-07 | 777 | 69 | 11 | 35844135 | |
| Pubmed | 3.83e-07 | 340 | 69 | 8 | 24332808 | ||
| Pubmed | CIRBP CDSN RBMXL3 AKAP8 FXR2 STARD9 RBM14 RBM5 EWSR1 FAM98A TAF15 KIF5B FLG2 YTHDF2 | 4.16e-07 | 1371 | 69 | 14 | 36244648 | |
| Pubmed | CIRBP DDX17 AKAP8 FXR2 MYO10 RBM14 FAM98A HNRNPA1L2 ECI2 FUS FLG2 YTHDF2 | 4.28e-07 | 971 | 69 | 12 | 33306668 | |
| Pubmed | The PRMT5/WDR77 complex regulates alternative splicing through ZNF326 in breast cancer. | 4.95e-07 | 147 | 69 | 6 | 28977470 | |
| Pubmed | 5.72e-07 | 244 | 69 | 7 | 29884807 | ||
| Pubmed | 5.83e-07 | 494 | 69 | 9 | 26831064 | ||
| Pubmed | 5.88e-07 | 245 | 69 | 7 | 21182205 | ||
| Pubmed | 5.88e-07 | 245 | 69 | 7 | 35652658 | ||
| Pubmed | TTF-1/NKX2-1 binds to DDB1 and confers replication stress resistance to lung adenocarcinomas. | 6.03e-07 | 152 | 69 | 6 | 28192407 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | NEFL DDX17 TCF20 AKAP8 NUP98 RBM14 EWSR1 TAF15 KIF5B FUS HNRNPUL1 HRNR | 7.49e-07 | 1024 | 69 | 12 | 24711643 |
| Pubmed | DDX17 RBMXL3 RBM14 EWSR1 FAM98A TAF15 HNRNPA1L2 FUS HNRNPUL1 HRNR YTHDF2 | 8.15e-07 | 844 | 69 | 11 | 25963833 | |
| Pubmed | CIRBP DDX17 AKAP8 FXR2 NUP98 RBM14 RBM5 EWSR1 FAM98A TAF15 FUS | 8.44e-07 | 847 | 69 | 11 | 35850772 | |
| Pubmed | 8.88e-07 | 10 | 69 | 3 | 21956701 | ||
| Pubmed | Identification of a USP9X Substrate NFX1-123 by SILAC-Based Quantitative Proteomics. | 9.54e-07 | 384 | 69 | 8 | 31059266 | |
| Pubmed | DBIRD complex integrates alternative mRNA splicing with RNA polymerase II transcript elongation. | 9.67e-07 | 89 | 69 | 5 | 22446626 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | GRIP1 TCF20 AKAP8 STARD9 RBM14 HELZ FAM98A KIF5B HNRNPUL1 YTHDF2 DOP1A | 9.90e-07 | 861 | 69 | 11 | 36931259 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | DDX17 AKAP8 RBM14 EWSR1 RNF40 FAM98A TAF15 HNRNPA1L2 KIF5B FUS HNRNPUL1 MED12 YTHDF2 | 9.94e-07 | 1257 | 69 | 13 | 37317656 |
| Pubmed | 1.02e-06 | 90 | 69 | 5 | 33087562 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | HMBOX1 DDX17 TCF20 AKAP8 NUP98 RBM14 RBM5 EWSR1 RNF40 TAF15 FUS HNRNPUL1 CREB1 | 1.37e-06 | 1294 | 69 | 13 | 30804502 |
| Pubmed | 1.37e-06 | 711 | 69 | 10 | 33022573 | ||
| Pubmed | DDX17 EWSR1 HNRNPA1L2 KIF5B FUS HNRNPUL1 ATP1B2 SYNPR YTHDF2 | 1.46e-06 | 552 | 69 | 9 | 36293380 | |
| Pubmed | Histone-binding of DPF2 mediates its repressive role in myeloid differentiation. | 1.54e-06 | 283 | 69 | 7 | 28533407 | |
| Pubmed | CIRBP DDX17 TCF20 EBF3 RBM14 RBM5 EWSR1 KIF5B FUS HNRNPUL1 CREB1 MED12 | 1.62e-06 | 1103 | 69 | 12 | 34189442 | |
| Pubmed | 1.65e-06 | 286 | 69 | 7 | 32041737 | ||
| Pubmed | 2.03e-06 | 425 | 69 | 8 | 24999758 | ||
| Pubmed | 2.16e-06 | 298 | 69 | 7 | 30737378 | ||
| Pubmed | 2.17e-06 | 46 | 69 | 4 | 20890123 | ||
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | 2.18e-06 | 580 | 69 | 9 | 35676659 | |
| Pubmed | ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure. | 3.12e-06 | 315 | 69 | 7 | 26777405 | |
| Pubmed | 3.25e-06 | 317 | 69 | 7 | 30997501 | ||
| Pubmed | 3.44e-06 | 115 | 69 | 5 | 17332742 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | CIRBP DDX17 FXR2 PRIM2 RBM14 EWSR1 RNF40 FAM98A KIF5B ECI2 FUS HNRNPUL1 FLG2 | 3.66e-06 | 1415 | 69 | 13 | 28515276 |
| Pubmed | Primary pulmonary myxoid sarcoma with EWSR1-CREB1 fusion: a new tumor entity. | 3.88e-06 | 2 | 69 | 2 | 21997693 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 8921363 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 31961321 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 26844702 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 31994243 | ||
| Pubmed | Evaluating the role of the FUS/TLS-related gene EWSR1 in amyotrophic lateral sclerosis. | 3.88e-06 | 2 | 69 | 2 | 22454397 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 26573619 | ||
| Pubmed | Genomic structure of the human RBP56/hTAFII68 and FUS/TLS genes. | 3.88e-06 | 2 | 69 | 2 | 9795213 | |
| Pubmed | Quantitative transportomics identifies Kif5a as a major regulator of neurodegeneration. | 3.88e-06 | 2 | 69 | 2 | 35259089 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 34193943 | ||
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 8954779 | ||
| Pubmed | EWSR1-CREB1 is the predominant gene fusion in angiomatoid fibrous histiocytoma. | 3.88e-06 | 2 | 69 | 2 | 17724745 | |
| Pubmed | 3.88e-06 | 2 | 69 | 2 | 1607388 | ||
| Pubmed | DDX17 is involved in DNA damage repair and modifies FUS toxicity in an RGG-domain dependent manner. | 3.88e-06 | 2 | 69 | 2 | 34061233 | |
| Pubmed | NEFL DDX17 STARD9 NUP98 RBM5 DLG3 FAM98A TAF15 HNRNPA1L2 KIF5A KIF5B FUS DOP1A | 4.50e-06 | 1442 | 69 | 13 | 35575683 | |
| Pubmed | 4.98e-06 | 17 | 69 | 3 | 15242798 | ||
| Pubmed | The RNA-binding protein HuR is a novel target of Pirh2 E3 ubiquitin ligase. | 5.14e-06 | 220 | 69 | 6 | 34091597 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 5.14e-06 | 220 | 69 | 6 | 35785414 | |
| Pubmed | 5.97e-06 | 18 | 69 | 3 | 24735878 | ||
| Interaction | CUL2 interactions | CIRBP SOX9 DDX17 MYO10 RBM14 DLG3 EWSR1 FAM98A TAF15 KIF5B FUS HNRNPUL1 HRNR FLG2 | 8.56e-09 | 591 | 68 | 14 | int:CUL2 |
| Interaction | ZBTB7B interactions | DDX17 TCF20 FXR2 MYO10 RBM14 EWSR1 KIF5A FUS HNRNPUL1 CREB1 YTHDF2 | 3.71e-08 | 366 | 68 | 11 | int:ZBTB7B |
| Interaction | CREBBP interactions | GRIP1 SOX9 ZEB1 DDX17 HIPK1 NUP98 RBM5 HELZ EWSR1 KIF5A FUS CREB1 YTHDF2 | 8.69e-08 | 599 | 68 | 13 | int:CREBBP |
| Interaction | NUP35 interactions | TCF20 AKAP8 NUP98 RBM14 HELZ EWSR1 HNRNPA1L2 FUS ZMIZ1 YTHDF2 USP47 | 1.64e-07 | 424 | 68 | 11 | int:NUP35 |
| Interaction | MECP2 interactions | CIRBP NEFL CDSN DDX17 TCF20 AKAP8 FXR2 EBF3 RBM14 RBM5 EWSR1 TAF15 FUS HNRNPUL1 HRNR FLG2 CREB1 MED12 | 1.66e-07 | 1287 | 68 | 18 | int:MECP2 |
| Interaction | CHD3 interactions | HMBOX1 NEFL DDX17 AKAP8 FXR2 RBM14 RBM5 EWSR1 FAM98A TAF15 FUS HRNR FLG2 CREB1 | 1.85e-07 | 757 | 68 | 14 | int:CHD3 |
| Interaction | FMR1 interactions | CIRBP HMBOX1 NEFL TCF20 AKAP8 FXR2 DVL2 RBM14 EWSR1 KIF5A KIF5B YTHDF2 | 2.08e-07 | 536 | 68 | 12 | int:FMR1 |
| Interaction | BTRC interactions | SOX9 DDX17 AKAP8 MYO10 RBM14 RBM5 EWSR1 FAM98A FUS HNRNPUL1 HRNR FLG2 YTHDF2 USP47 | 2.46e-07 | 775 | 68 | 14 | int:BTRC |
| Interaction | TLE3 interactions | 5.04e-07 | 376 | 68 | 10 | int:TLE3 | |
| Interaction | GLDC interactions | 1.27e-06 | 321 | 68 | 9 | int:GLDC | |
| Interaction | DDX17 interactions | 1.56e-06 | 426 | 68 | 10 | int:DDX17 | |
| Interaction | DDX3X interactions | DDX17 FXR2 RBM14 EWSR1 FAM98A TAF15 FUS HNRNPUL1 HRNR FLG2 MED12 YTHDF2 | 1.62e-06 | 651 | 68 | 12 | int:DDX3X |
| Interaction | BMI1 interactions | CIRBP AKAP8 FXR2 RBM14 HELZ EWSR1 TAF15 KIF5B FUS HNRNPUL1 MED12 YTHDF2 | 1.84e-06 | 659 | 68 | 12 | int:BMI1 |
| Interaction | PRMT1 interactions | CIRBP GRIP1 NEFL DDX17 AKAP8 RBM14 RBM5 EWSR1 FAM98A TAF15 KIF5B FUS HNRNPUL1 YTHDF2 | 2.14e-06 | 929 | 68 | 14 | int:PRMT1 |
| Interaction | HNRNPA1 interactions | CIRBP DDX17 AKAP8 RBM14 RBM5 EWSR1 TAF15 BRINP1 HNRNPA1L2 FUS HNRNPUL1 HRNR FLG2 YTHDF2 | 2.61e-06 | 945 | 68 | 14 | int:HNRNPA1 |
| Interaction | TRIM31 interactions | DDX17 AKAP8 FXR2 RBM14 EWSR1 FAM98A TAF15 FUS HNRNPUL1 USP47 | 2.76e-06 | 454 | 68 | 10 | int:TRIM31 |
| Interaction | DDX5 interactions | OTX2 ZEB1 DDX17 AKAP8 RBM14 EWSR1 RNF40 TAF15 FUS HNRNPUL1 MED12 | 2.89e-06 | 568 | 68 | 11 | int:DDX5 |
| Interaction | YWHAG interactions | GRIP1 NEFL DDX17 AKAP8 STARD9 DVL2 RBM14 HELZ EWSR1 FAM98A TAF15 KIF5A KIF5B HNRNPUL1 YTHDF2 DOP1A | 2.92e-06 | 1248 | 68 | 16 | int:YWHAG |
| Interaction | COPS5 interactions | CIRBP ZEB1 DDX17 AKAP8 RBM14 RBM5 EWSR1 FAM98A TAF15 KIF5B FUS HNRNPUL1 HRNR FLG2 YTHDF2 | 3.06e-06 | 1102 | 68 | 15 | int:COPS5 |
| Interaction | OTUB1 interactions | 3.12e-06 | 358 | 68 | 9 | int:OTUB1 | |
| Interaction | KHDRBS1 interactions | 4.36e-06 | 373 | 68 | 9 | int:KHDRBS1 | |
| Interaction | ARAF interactions | 4.65e-06 | 376 | 68 | 9 | int:ARAF | |
| Interaction | HDLBP interactions | CIRBP CDSN RBMXL3 AKAP8 FXR2 RBM14 RBM5 EWSR1 TAF15 KIF5B FLG2 YTHDF2 USP47 | 4.75e-06 | 855 | 68 | 13 | int:HDLBP |
| Interaction | ARMC5 interactions | 5.12e-06 | 201 | 68 | 7 | int:ARMC5 | |
| Interaction | SIRT7 interactions | NEFL TCF20 FXR2 NUP98 HELZ EWSR1 TAF15 KIF5B FUS HNRNPUL1 MED12 USP47 | 6.40e-06 | 744 | 68 | 12 | int:SIRT7 |
| Interaction | FZR1 interactions | CIRBP MET DDX17 AKAP8 FXR2 MYO10 NUP98 RBM14 FAM98A HNRNPA1L2 ECI2 FUS EYA1 FLG2 YTHDF2 | 6.48e-06 | 1172 | 68 | 15 | int:FZR1 |
| Interaction | CAND1 interactions | CIRBP DDX17 AKAP8 FXR2 MYO10 RBM14 EWSR1 RNF40 FAM98A TAF15 FUS HNRNPUL1 YTHDF2 | 7.69e-06 | 894 | 68 | 13 | int:CAND1 |
| Interaction | SNRNP40 interactions | DDX17 TCF20 AKAP8 PRIM2 RBM14 RBM5 EWSR1 TAF15 FUS HNRNPUL1 MED12 | 8.61e-06 | 637 | 68 | 11 | int:SNRNP40 |
| Interaction | DAZL interactions | 9.48e-06 | 145 | 68 | 6 | int:DAZL | |
| Interaction | MYCN interactions | CIRBP DDX17 TCF20 AKAP8 FXR2 LORICRIN RBM14 EWSR1 FAM98A TAF15 HNRNPA1L2 FUS HNRNPUL1 HRNR FLG2 CREB1 | 9.86e-06 | 1373 | 68 | 16 | int:MYCN |
| Interaction | EP300 interactions | GRIP1 SOX9 ZEB1 DDX17 AKAP8 NUP98 DVL2 RBM14 EWSR1 RNF40 TAF15 KIF5B FUS HNRNPUL1 CREB1 SLC33A1 | 1.27e-05 | 1401 | 68 | 16 | int:EP300 |
| Interaction | RC3H2 interactions | DDX17 AKAP8 FXR2 RBM14 HELZ EWSR1 FAM98A TAF15 FUS HNRNPUL1 YTHDF2 | 1.32e-05 | 667 | 68 | 11 | int:RC3H2 |
| Interaction | FXR2 interactions | 1.36e-05 | 430 | 68 | 9 | int:FXR2 | |
| Interaction | YAP1 interactions | ZEB1 DDX17 TCF20 RBM14 HNRNPA1L2 KIF5A KIF5B FUS HNRNPUL1 HRNR FLG2 CREB1 MED12 USP47 | 1.41e-05 | 1095 | 68 | 14 | int:YAP1 |
| Interaction | METTL14 interactions | 1.68e-05 | 558 | 68 | 10 | int:METTL14 | |
| Interaction | CDK9 interactions | DDX17 MYO10 NUP98 RBM14 EWSR1 RNF40 TAF15 KIF5B FUS PGC MED12 | 1.70e-05 | 685 | 68 | 11 | int:CDK9 |
| Interaction | RNF113A interactions | DDX17 AKAP8 FXR2 NUP98 RBM14 HELZ EWSR1 TAF15 FUS HNRNPUL1 YTHDF2 | 1.86e-05 | 692 | 68 | 11 | int:RNF113A |
| Interaction | CIT interactions | NEFL DDX17 RBMXL3 TCF20 FXR2 HIPK1 NUP98 RBM14 RBM5 RNF40 FAM98A TAF15 HNRNPA1L2 ECI2 FUS HNRNPUL1 | 1.95e-05 | 1450 | 68 | 16 | int:CIT |
| Interaction | FBP1 interactions | 2.19e-05 | 348 | 68 | 8 | int:FBP1 | |
| Interaction | MIRLET7D interactions | 2.32e-05 | 101 | 68 | 5 | int:MIRLET7D | |
| Interaction | RBMX interactions | 2.36e-05 | 461 | 68 | 9 | int:RBMX | |
| Interaction | NFX1 interactions | 2.57e-05 | 466 | 68 | 9 | int:NFX1 | |
| Interaction | CTNNB1 interactions | GRIP1 HMBOX1 MET DDX17 NUP98 DVL2 RBM14 EWSR1 KIF5B FUS ZMIZ1 CREB1 YTHDF2 | 2.77e-05 | 1009 | 68 | 13 | int:CTNNB1 |
| Interaction | MIRLET7E interactions | 2.93e-05 | 106 | 68 | 5 | int:MIRLET7E | |
| Interaction | NKX2-1 interactions | 3.23e-05 | 180 | 68 | 6 | int:NKX2-1 | |
| Interaction | DCUN1D1 interactions | 3.89e-05 | 275 | 68 | 7 | int:DCUN1D1 | |
| Interaction | MIRLET7I interactions | 4.16e-05 | 114 | 68 | 5 | int:MIRLET7I | |
| Interaction | HNF1B interactions | 4.37e-05 | 190 | 68 | 6 | int:HNF1B | |
| Interaction | EWSR1 interactions | OTX2 ZEB1 DDX17 TCF20 AKAP8 FXR2 EWSR1 RNF40 TAF15 FUS HNRNPUL1 HRNR | 4.51e-05 | 906 | 68 | 12 | int:EWSR1 |
| Interaction | RNU1-1 interactions | 4.68e-05 | 21 | 68 | 3 | int:RNU1-1 | |
| Interaction | MIRLET7G interactions | 4.71e-05 | 117 | 68 | 5 | int:MIRLET7G | |
| Interaction | HEXIM1 interactions | CIRBP DDX17 RBM14 EWSR1 FAM98A TAF15 HNRNPA1L2 KIF5A KIF5B FUS HNRNPUL1 HRNR | 4.86e-05 | 913 | 68 | 12 | int:HEXIM1 |
| Interaction | SAFB2 interactions | 5.05e-05 | 195 | 68 | 6 | int:SAFB2 | |
| Interaction | CELF1 interactions | 5.21e-05 | 288 | 68 | 7 | int:CELF1 | |
| Interaction | BRCA1 interactions | HMBOX1 DDX17 AKAP8 FXR2 RBM14 EWSR1 FAM98A TAF15 KIF5B FUS ZMIZ1 HNRNPUL1 CREB1 MED12 | 6.02e-05 | 1249 | 68 | 14 | int:BRCA1 |
| Interaction | TARDBP interactions | 6.03e-05 | 520 | 68 | 9 | int:TARDBP | |
| Interaction | SOX2 interactions | ZEB1 DDX17 TCF20 AKAP8 NUP98 RBM14 RBM5 HELZ EWSR1 FAM98A TAF15 FUS EYA1 CREB1 YTHDF2 | 6.27e-05 | 1422 | 68 | 15 | int:SOX2 |
| Interaction | FUBP3 interactions | 6.32e-05 | 297 | 68 | 7 | int:FUBP3 | |
| Interaction | UBE2I interactions | 6.44e-05 | 654 | 68 | 10 | int:UBE2I | |
| Interaction | CPSF6 interactions | 6.58e-05 | 526 | 68 | 9 | int:CPSF6 | |
| Interaction | TAF15 interactions | 6.74e-05 | 408 | 68 | 8 | int:TAF15 | |
| Interaction | RBM45 interactions | 7.04e-05 | 207 | 68 | 6 | int:RBM45 | |
| Interaction | MARF1 interactions | 7.23e-05 | 128 | 68 | 5 | int:MARF1 | |
| Interaction | TP53BP1 interactions | 7.28e-05 | 533 | 68 | 9 | int:TP53BP1 | |
| Interaction | SF1 interactions | 7.32e-05 | 304 | 68 | 7 | int:SF1 | |
| Interaction | KHDRBS2 interactions | 7.50e-05 | 129 | 68 | 5 | int:KHDRBS2 | |
| Interaction | EFTUD2 interactions | CIRBP DDX17 FXR2 PRIM2 RBM14 EWSR1 RNF40 FAM98A TAF15 KIF5B ECI2 FUS HNRNPUL1 FLG2 MED12 | 7.76e-05 | 1449 | 68 | 15 | int:EFTUD2 |
| Interaction | TDRD3 interactions | 8.03e-05 | 212 | 68 | 6 | int:TDRD3 | |
| Interaction | MIR138-1 interactions | 8.20e-05 | 68 | 68 | 4 | int:MIR138-1 | |
| Interaction | RC3H1 interactions | CIRBP DDX17 FXR2 RBM14 HELZ EWSR1 FAM98A FUS HNRNPUL1 YTHDF2 | 8.58e-05 | 677 | 68 | 10 | int:RC3H1 |
| Interaction | PRC1 interactions | NEFL DDX17 RBMXL3 AKAP8 FXR2 NUP98 RBM14 TAF15 HNRNPA1L2 FUS HNRNPUL1 HRNR | 8.95e-05 | 973 | 68 | 12 | int:PRC1 |
| Interaction | MIR9-3 interactions | 9.19e-05 | 70 | 68 | 4 | int:MIR9-3 | |
| Interaction | RNF43 interactions | 9.25e-05 | 427 | 68 | 8 | int:RNF43 | |
| Interaction | CMTR1 interactions | 9.36e-05 | 218 | 68 | 6 | int:CMTR1 | |
| Interaction | MIR140 interactions | 9.72e-05 | 71 | 68 | 4 | int:MIR140 | |
| Interaction | SMG7 interactions | 9.88e-05 | 319 | 68 | 7 | int:SMG7 | |
| Interaction | RTRAF interactions | 1.03e-04 | 222 | 68 | 6 | int:RTRAF | |
| Interaction | AR interactions | GRIP1 NEFL DDX17 TCF20 RBM14 RNF40 TAF15 ZMIZ1 HNRNPUL1 HRNR CREB1 MED12 | 1.08e-04 | 992 | 68 | 12 | int:AR |
| Interaction | MIR18A interactions | 1.08e-04 | 73 | 68 | 4 | int:MIR18A | |
| Interaction | MIR29B1 interactions | 1.08e-04 | 73 | 68 | 4 | int:MIR29B1 | |
| Interaction | SRSF9 interactions | 1.09e-04 | 224 | 68 | 6 | int:SRSF9 | |
| Interaction | ZNF326 interactions | 1.09e-04 | 224 | 68 | 6 | int:ZNF326 | |
| Interaction | RUNX1 interactions | 1.09e-04 | 324 | 68 | 7 | int:RUNX1 | |
| Interaction | SFPQ interactions | 1.10e-04 | 563 | 68 | 9 | int:SFPQ | |
| Interaction | MIR20A interactions | 1.14e-04 | 74 | 68 | 4 | int:MIR20A | |
| Interaction | SMC5 interactions | DDX17 TCF20 NUP98 RBM14 EWSR1 FAM98A TAF15 HNRNPA1L2 FUS HNRNPUL1 CREB1 YTHDF2 | 1.16e-04 | 1000 | 68 | 12 | int:SMC5 |
| Interaction | CUL5 interactions | 1.17e-04 | 567 | 68 | 9 | int:CUL5 | |
| Interaction | THRAP3 interactions | 1.19e-04 | 443 | 68 | 8 | int:THRAP3 | |
| Interaction | MIR15A interactions | 1.20e-04 | 75 | 68 | 4 | int:MIR15A | |
| Interaction | HNRNPK interactions | CIRBP OTX2 DDX17 AKAP8 DVL2 RBM14 EWSR1 TAF15 FUS CREB1 YTHDF2 | 1.23e-04 | 853 | 68 | 11 | int:HNRNPK |
| Interaction | MIR7-3 interactions | 1.27e-04 | 76 | 68 | 4 | int:MIR7-3 | |
| Interaction | MIR16-1 interactions | 1.27e-04 | 76 | 68 | 4 | int:MIR16-1 | |
| Interaction | MIR199A2 interactions | 1.27e-04 | 76 | 68 | 4 | int:MIR199A2 | |
| Interaction | NCOA6 interactions | 1.30e-04 | 145 | 68 | 5 | int:NCOA6 | |
| Interaction | PRPF19 interactions | 1.33e-04 | 450 | 68 | 8 | int:PRPF19 | |
| Interaction | MIR9-2 interactions | 1.33e-04 | 77 | 68 | 4 | int:MIR9-2 | |
| Interaction | MIR200A interactions | 1.33e-04 | 77 | 68 | 4 | int:MIR200A | |
| Interaction | CCAR2 interactions | 1.39e-04 | 337 | 68 | 7 | int:CCAR2 | |
| Interaction | MIR98 interactions | 1.40e-04 | 78 | 68 | 4 | int:MIR98 | |
| Interaction | HNRNPM interactions | 1.47e-04 | 723 | 68 | 10 | int:HNRNPM | |
| Cytoband | 17p13.1 | 7.66e-04 | 118 | 69 | 3 | 17p13.1 | |
| Cytoband | 22q11.2 | 8.05e-04 | 120 | 69 | 3 | 22q11.2 | |
| Cytoband | 1p13.2 | 2.21e-03 | 46 | 69 | 2 | 1p13.2 | |
| GeneFamily | RNA binding motif containing | 4.82e-08 | 213 | 45 | 8 | 725 | |
| GeneFamily | Zinc fingers RANBP2-type |RNA binding motif containing | 1.94e-07 | 21 | 45 | 4 | 89 | |
| GeneFamily | EF-hand domain containing|S100 fused type protein family | 1.26e-04 | 7 | 45 | 2 | 1350 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 2.03e-04 | 46 | 45 | 3 | 622 | |
| GeneFamily | Immunoglobulin lambda locus at 22q11.2 | 1.41e-03 | 89 | 45 | 3 | 353 | |
| GeneFamily | PDZ domain containing | 6.38e-03 | 152 | 45 | 3 | 1220 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.04e-05 | 186 | 69 | 5 | 73cf266aeecd3cc15e8cb6094588a393bca8fbe6 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal-midbrain/hindbrain_cells|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 1.34e-05 | 196 | 69 | 5 | 0767581b69bc7e6334d580ca02ed1e831b7b55da | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon|organoid_Velasco_nature / Sample Type, Dataset, Time_group, and Cell type. | 1.40e-05 | 198 | 69 | 5 | a6f65bb0845d8f64f5c7edb00cee3ca5adb1a373 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Radial_glial-oRG|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.40e-05 | 198 | 69 | 5 | 72dc49aa107d0cc6206eb67b577c73e190855125 | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-vRG-20|World / Primary Cells by Cluster | 1.40e-05 | 198 | 69 | 5 | bce0bc1e3f2257e0f42a1fa6e5b57cf71e4514ba | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Radial_glial-oRG|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.44e-05 | 199 | 69 | 5 | 151bda6821b52cfb4491474892ecb45781522837 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 1.44e-05 | 199 | 69 | 5 | f30e9d3d095a1e12d759debe27540aad32861db6 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3_mon-Radial_glial|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.47e-05 | 200 | 69 | 5 | 49197316231e45f8c9f007f55b036600f7195922 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3_mon-Radial_glial-RG|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.47e-05 | 200 | 69 | 5 | dea7928d6ceb7a347f56c6d0c9c7a56b7a2c0a80 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 8.90e-05 | 151 | 69 | 4 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.13e-05 | 152 | 69 | 4 | 1b2a39ae159e79f1fb18d6d164bd7acab5299fca | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.14e-04 | 161 | 69 | 4 | 2d63b279d9a5132e1c09b03930bf9039036d24a2 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 161 | 69 | 4 | 69f5e759c0925daa37e0177a9cc3154842906bf6 | |
| ToppCell | facs-Thymus-Epithelium-3m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 162 | 69 | 4 | 25323785dd33337bcefd05958a4a1a208a9ceb04 | |
| ToppCell | facs-Thymus-Epithelium-3m-Epithelial-epithelial_cell_of_thymus|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 162 | 69 | 4 | 3dc39db0d5f6f3d7bcc312a6bce7aaeb914138d1 | |
| ToppCell | facs-Thymus-Epithelium-3m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 162 | 69 | 4 | 0a7138266054ea5954649c8b61ef93905d56b068 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)-DC2_L.1.2.1.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.25e-04 | 165 | 69 | 4 | 76abebe80e5f8bf44825bb619ae86fcb6f66ffeb | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 165 | 69 | 4 | 02cd87dfa2ca40e13455a4b9308477e82f76289b | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 165 | 69 | 4 | 6d8b5669eee9b0903c9260fea707d186c9d7fefa | |
| ToppCell | Tuft-tuft-1|World / Class top | 1.34e-04 | 168 | 69 | 4 | 8ddc2ec483ed2c6c0fb2ae521c6861ceb6d32e34 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.34e-04 | 168 | 69 | 4 | ca94b29c1030484143a77f2df06dad74d2c6136e | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue-Breast_normal_tissue|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.54e-04 | 174 | 69 | 4 | 0f3ec0d0d4344e10c9b48adc9174123f6402dc51 | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue-Breast_normal_tissue-3|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.54e-04 | 174 | 69 | 4 | 7f8f5fafae08676d2b90cab9802c3c9320f1370e | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.54e-04 | 174 | 69 | 4 | e2f240d60bffbe8e6d60f0bb405b231bd3c96875 | |
| ToppCell | Adult-Epithelial-basal_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.54e-04 | 174 | 69 | 4 | a4f98afe7d1cc2617f6f7bc8092c41df57474b30 | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.54e-04 | 174 | 69 | 4 | 1aadbf2642b6d1320ceabd92e6ff59e11f16c315 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.68e-04 | 178 | 69 | 4 | fba2e38c05cbf031e0c6d47b1602575fea734a57 | |
| ToppCell | Epithelial-basal_cell|World / Lineage, Cell type, age group and donor | 1.71e-04 | 179 | 69 | 4 | d9be6647ec7b22747dc00dce4ea307b6af412dfa | |
| ToppCell | 10x5'-Lung-Lymphocytic_B_plasma-Plasmablasts|Lung / Manually curated celltypes from each tissue | 1.71e-04 | 179 | 69 | 4 | 3fa75eec3e86fd1797eaa33362257df7f9b2a0bf | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.79e-04 | 181 | 69 | 4 | 9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.82e-04 | 182 | 69 | 4 | eb138aa1dca9373f1586600f258df06dcf56d81f | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.82e-04 | 182 | 69 | 4 | d1a1feef318062f25493355d7beee8e5fb0e4206 | |
| ToppCell | Adult-Epithelial-basal_cell|Adult / Lineage, Cell type, age group and donor | 1.86e-04 | 183 | 69 | 4 | 00a6b19ca49e3b8e0d1cd387a3515b0ff4b81c81 | |
| ToppCell | wk_08-11-Epithelial-PNS-PCP4+_neuron|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.90e-04 | 184 | 69 | 4 | eac2a9089913f33a961ba11519b53645790f2056 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.94e-04 | 185 | 69 | 4 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.98e-04 | 186 | 69 | 4 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.98e-04 | 186 | 69 | 4 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_basal|COVID-19 / group, cell type (main and fine annotations) | 2.02e-04 | 187 | 69 | 4 | 8407a82e98f56a94ea26562bcb6bbe00a8f41661 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.06e-04 | 188 | 69 | 4 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.11e-04 | 189 | 69 | 4 | 0e8d1be3c406d1a393e18faccfe89116a8f82bcf | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Astro|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.15e-04 | 190 | 69 | 4 | 78cc6c28b31de041c24175a98f47da256ecc15a2 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-oRG/Astrocyte-7|World / Primary Cells by Cluster | 2.15e-04 | 190 | 69 | 4 | 8f1c490dd8e5f80382f5294fd1aa8cba4c3c647f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Astro-Astrocyte|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.15e-04 | 190 | 69 | 4 | e67d9400467b438592690b23d681e6c2fb8f09fd | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-oRG/Astrocyte|World / Primary Cells by Cluster | 2.15e-04 | 190 | 69 | 4 | 7dbfd543398c63cbe1e68b54bcb5e2291f521935 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.19e-04 | 191 | 69 | 4 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.24e-04 | 192 | 69 | 4 | d0649410cf5eacdb0c1dce70e37c7473ef5fddfa | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.24e-04 | 192 | 69 | 4 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.24e-04 | 192 | 69 | 4 | 43beaac1de99b9c1a6dab4a450b4e81286987b64 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.28e-04 | 193 | 69 | 4 | b03d908d4b8940927f72c76a1b0f237d13f39056 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-oRG-34|World / Primary Cells by Cluster | 2.28e-04 | 193 | 69 | 4 | d55f792eb3db10452347681131e07e041348fd89 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.28e-04 | 193 | 69 | 4 | 40edc07b6e7f19f6ee885fa5af0b63ef1b0f2468 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.33e-04 | 194 | 69 | 4 | 68004855b23fe1e31e8452d70effabc78a4a0bd3 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.33e-04 | 194 | 69 | 4 | 6b286992d4bb56013c0ea5a7601d3476d806175a | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-oRG|World / Primary Cells by Cluster | 2.33e-04 | 194 | 69 | 4 | 3a4bf6a7fac0e5bdbb4bb17041806d06a75974d9 | |
| ToppCell | MatrixFB-Fibroblast-B_(Myofibroblast)|MatrixFB / shred on cell class and cell subclass (v4) | 2.42e-04 | 196 | 69 | 4 | 38ea0eaf42f95c321ca23570d0d7752980cf00f8 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon|organoid_Paulsen_bioRxiv / Sample Type, Dataset, Time_group, and Cell type. | 2.47e-04 | 197 | 69 | 4 | 58b957efd006f43c2fe55071d5c6d06c2e367e72 | |
| ToppCell | Tracheal-10x5prime-Stromal-Schwann-Schwann_nonmyelinating|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.47e-04 | 197 | 69 | 4 | e239caae24f40564a24ad909754f5436f767ccdb | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macro_interstitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.52e-04 | 198 | 69 | 4 | 9a77038e5db0ea757fd7ebcab294785b166ddc12 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-IN_Progenitors|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.52e-04 | 198 | 69 | 4 | 3811d9e3e54bbe8b208c591697e43b55ab5bbf0e | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Radial_glial|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.56e-04 | 199 | 69 | 4 | 0fee11bd72b27202f8d9fa4daba831ea9c8a61b2 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 2.61e-04 | 200 | 69 | 4 | e16bde12326f0cfc4d03f9307cba0e21ea2389cb | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Macroglial-Astrocyte|3m / Sample Type, Dataset, Time_group, and Cell type. | 2.61e-04 | 200 | 69 | 4 | 98d7f577b31a603bf835bf9b4ea31999445cf0e5 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Radial_glial|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 2.61e-04 | 200 | 69 | 4 | ed4a41cb6782541d8fc928aaa12cf03bc1c630a2 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.61e-04 | 200 | 69 | 4 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; PC3; HT_HG-U133A | 1.54e-06 | 189 | 68 | 7 | 4271_DN | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | 1.59e-05 | 179 | 68 | 6 | 4585_DN | |
| Drug | poly(G | 2.34e-05 | 114 | 68 | 5 | CID000439502 | |
| Drug | Fenoprofen calcium salt dihydrate [53746-45-5]; Down 200; 7.2uM; PC3; HT_HG-U133A | 2.36e-05 | 192 | 68 | 6 | 4274_DN | |
| Drug | Capsaicin [404-86-4]; Down 200; 13uM; PC3; HT_HG-U133A | 2.50e-05 | 194 | 68 | 6 | 4612_DN | |
| Drug | Sulfadoxine [2447-57-6]; Down 200; 12.8uM; PC3; HT_HG-U133A | 2.80e-05 | 198 | 68 | 6 | 5852_DN | |
| Disease | amyotrophic lateral sclerosis type 6 (implicated_via_orthology) | 9.73e-09 | 3 | 64 | 3 | DOID:0060198 (implicated_via_orthology) | |
| Disease | Congenital small ears | 1.92e-06 | 41 | 64 | 4 | C0152423 | |
| Disease | frontotemporal dementia (implicated_via_orthology) | 2.11e-06 | 12 | 64 | 3 | DOID:9255 (implicated_via_orthology) | |
| Disease | triglycerides to total lipids in small VLDL percentage | 7.82e-06 | 58 | 64 | 4 | EFO_0022338 | |
| Disease | triglycerides to total lipids in small LDL percentage | 8.37e-06 | 59 | 64 | 4 | EFO_0022337 | |
| Disease | triglycerides in small VLDL measurement | 9.57e-06 | 61 | 64 | 4 | EFO_0022145 | |
| Disease | triglycerides in small HDL measurement | 1.02e-05 | 62 | 64 | 4 | EFO_0022158 | |
| Disease | triglycerides to total lipids in IDL percentage | 1.09e-05 | 63 | 64 | 4 | EFO_0022329 | |
| Disease | triglycerides to total lipids in medium VLDL percentage | 1.09e-05 | 63 | 64 | 4 | EFO_0022335 | |
| Disease | cholesterol to total lipids in medium VLDL percentage | 1.09e-05 | 63 | 64 | 4 | EFO_0022239 | |
| Disease | free cholesterol to total lipids in medium LDL percentage | 1.09e-05 | 63 | 64 | 4 | EFO_0022283 | |
| Disease | cholesteryl esters to total lipids in medium VLDL percentage | 1.16e-05 | 64 | 64 | 4 | EFO_0022253 | |
| Disease | cholesterol to total lipids in very small VLDL percentage | 1.39e-05 | 67 | 64 | 4 | EFO_0022245 | |
| Disease | Major Depressive Disorder | 1.47e-05 | 243 | 64 | 6 | C1269683 | |
| Disease | triglycerides to total lipids in very small VLDL percentage | 1.56e-05 | 69 | 64 | 4 | EFO_0022341 | |
| Disease | cholesteryl esters to total lipids in very small VLDL percentage | 1.75e-05 | 71 | 64 | 4 | EFO_0022259 | |
| Disease | free cholesterol to total lipids in large LDL percentage | 2.07e-05 | 74 | 64 | 4 | EFO_0022280 | |
| Disease | Unipolar Depression | 2.11e-05 | 259 | 64 | 6 | C0041696 | |
| Disease | free cholesterol to total lipids in small VLDL percentage | 2.18e-05 | 75 | 64 | 4 | EFO_0022287 | |
| Disease | Clear Cell Sarcoma of Soft Tissue | 2.77e-05 | 4 | 64 | 2 | C0206651 | |
| Disease | amyotrophic lateral sclerosis (implicated_via_orthology) | 3.79e-05 | 30 | 64 | 3 | DOID:332 (implicated_via_orthology) | |
| Disease | sarcoma (is_marker_for) | 4.61e-05 | 5 | 64 | 2 | DOID:1115 (is_marker_for) | |
| Disease | Extraskeletal Myxoid Chondrosarcoma | 4.61e-05 | 5 | 64 | 2 | C1275278 | |
| Disease | amyotrophic lateral sclerosis (is_implicated_in) | 4.61e-05 | 32 | 64 | 3 | DOID:332 (is_implicated_in) | |
| Disease | peeling skin syndrome (is_implicated_in) | 6.91e-05 | 6 | 64 | 2 | DOID:0060283 (is_implicated_in) | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 7.57e-05 | 103 | 64 | 4 | EFO_0008595, EFO_0020944 | |
| Disease | lipoprotein A measurement, apolipoprotein A 1 measurement | 9.66e-05 | 7 | 64 | 2 | EFO_0004614, EFO_0006925 | |
| Disease | spinal muscular atrophy (implicated_via_orthology) | 1.65e-04 | 9 | 64 | 2 | DOID:12377 (implicated_via_orthology) | |
| Disease | cholesteryl esters to total lipids in small VLDL percentage | 1.67e-04 | 49 | 64 | 3 | EFO_0022256 | |
| Disease | triglycerides to total lipids in medium LDL percentage | 1.77e-04 | 50 | 64 | 3 | EFO_0022334 | |
| Disease | polyunsaturated fatty acids to total fatty acids percentage | 1.77e-04 | 50 | 64 | 3 | EFO_0022303 | |
| Disease | cholesteryl esters to total lipids in IDL percentage | 1.77e-04 | 50 | 64 | 3 | EFO_0022247 | |
| Disease | polyunsaturated fatty acids to monounsaturated fatty acids ratio | 1.88e-04 | 51 | 64 | 3 | EFO_0022302 | |
| Disease | cholesterol to total lipids in small HDL percentage | 1.88e-04 | 51 | 64 | 3 | EFO_0022240 | |
| Disease | cholesterol to total lipids in small VLDL percentage | 1.88e-04 | 51 | 64 | 3 | EFO_0022242 | |
| Disease | free cholesterol to total lipids in small LDL percentage | 2.11e-04 | 53 | 64 | 3 | EFO_0022286 | |
| Disease | cholesteryl esters to total lipids in very large VLDL percentage | 2.11e-04 | 53 | 64 | 3 | EFO_0022258 | |
| Disease | cholesterol to total lipids in very large VLDL percentage | 2.23e-04 | 54 | 64 | 3 | EFO_0022244 | |
| Disease | cholesterol to total lipids in large HDL percentage | 2.36e-04 | 55 | 64 | 3 | EFO_0022234 | |
| Disease | triglycerides in very large VLDL measurement | 2.49e-04 | 56 | 64 | 3 | EFO_0022325 | |
| Disease | triglycerides to total lipids in medium HDL percentage | 2.49e-04 | 56 | 64 | 3 | EFO_0022333 | |
| Disease | triglycerides in chylomicrons and extremely large VLDL measurement | 2.49e-04 | 56 | 64 | 3 | EFO_0022316 | |
| Disease | free cholesterol to total lipids in large HDL percentage | 2.49e-04 | 56 | 64 | 3 | EFO_0022279 | |
| Disease | cholesteryl esters to total lipids in medium HDL percentage | 2.49e-04 | 56 | 64 | 3 | EFO_0022251 | |
| Disease | vascular dementia (is_marker_for) | 2.52e-04 | 11 | 64 | 2 | DOID:8725 (is_marker_for) | |
| Disease | free cholesterol to total lipids in medium VLDL percentage | 2.62e-04 | 57 | 64 | 3 | EFO_0022284 | |
| Disease | Amyotrophic Lateral Sclerosis | 2.76e-04 | 58 | 64 | 3 | C0002736 | |
| Disease | low density lipoprotein particle size measurement | 2.76e-04 | 58 | 64 | 3 | EFO_0008593 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 2.83e-04 | 145 | 64 | 4 | DOID:1289 (implicated_via_orthology) | |
| Disease | triglycerides in VLDL measurement | 2.90e-04 | 59 | 64 | 3 | EFO_0022326 | |
| Disease | concentration of chylomicrons and extremely large VLDL particles measurement | 2.90e-04 | 59 | 64 | 3 | EFO_0022260 | |
| Disease | triglyceride measurement, phospholipid measurement | 2.90e-04 | 146 | 64 | 4 | EFO_0004530, EFO_0004639 | |
| Disease | motor neuron disease (implicated_via_orthology) | 3.01e-04 | 12 | 64 | 2 | DOID:231 (implicated_via_orthology) | |
| Disease | triglycerides to total lipids in large HDL percentage | 3.05e-04 | 60 | 64 | 3 | EFO_0022330 | |
| Disease | cholesterol in chylomicrons and extremely large VLDL measurement | 3.05e-04 | 60 | 64 | 3 | EFO_0021898 | |
| Disease | cholesterol to total lipids in IDL percentage | 3.05e-04 | 60 | 64 | 3 | EFO_0022233 | |
| Disease | cholesterol to total lipids in medium HDL percentage | 3.05e-04 | 60 | 64 | 3 | EFO_0022237 | |
| Disease | free cholesterol in very large VLDL measurement | 3.20e-04 | 61 | 64 | 3 | EFO_0022274 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 3.22e-04 | 150 | 64 | 4 | EFO_0004611, EFO_0020947 | |
| Disease | triglycerides to total lipids in very large HDL percentage | 3.36e-04 | 62 | 64 | 3 | EFO_0022339 | |
| Disease | phospholipids in large VLDL measurement | 3.36e-04 | 62 | 64 | 3 | EFO_0022169 | |
| Disease | total lipids in chylomicrons and extremely large VLDL measurement | 3.36e-04 | 62 | 64 | 3 | EFO_0022306 | |
| Disease | total lipids in very large VLDL measurement | 3.36e-04 | 62 | 64 | 3 | EFO_0022313 | |
| Disease | free cholesterol in chylomicrons and extremely large VLDL measurement | 3.36e-04 | 62 | 64 | 3 | EFO_0022263 | |
| Disease | phospholipids in very large VLDL measurement | 3.36e-04 | 62 | 64 | 3 | EFO_0022299 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 3.38e-04 | 152 | 64 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | phospholipids in chylomicrons and extremely large VLDL measurement | 3.52e-04 | 63 | 64 | 3 | EFO_0022292 | |
| Disease | triglycerides in small LDL measurement | 3.86e-04 | 65 | 64 | 3 | EFO_0022323 | |
| Disease | total lipids in very large HDL measurement | 4.04e-04 | 66 | 64 | 3 | EFO_0022312 | |
| Disease | phospholipids in very large HDL measurement | 4.04e-04 | 66 | 64 | 3 | EFO_0022298 | |
| Disease | triglycerides to phosphoglycerides ratio | 4.41e-04 | 68 | 64 | 3 | EFO_0022327 | |
| Disease | free cholesterol in large VLDL measurement | 4.41e-04 | 68 | 64 | 3 | EFO_0022265 | |
| Disease | cholesterol in very large HDL measurement | 4.60e-04 | 69 | 64 | 3 | EFO_0022229 | |
| Disease | triglycerides to total lipids in chylomicrons and extremely large VLDL percentage | 4.77e-04 | 15 | 64 | 2 | EFO_0022328 | |
| Disease | triglycerides to total lipids in small HDL percentage | 5.22e-04 | 72 | 64 | 3 | EFO_0022336 | |
| Disease | cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 6.17e-04 | 17 | 64 | 2 | EFO_0022232 | |
| Disease | monounsaturated fatty acids; 16:1, 18:1 measurement | 6.59e-04 | 78 | 64 | 3 | EFO_0022187 | |
| Disease | free cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 9.47e-04 | 21 | 64 | 2 | EFO_0022277 | |
| Disease | cholesteryl esters to total lipids in chylomicrons and extremely large VLDL percentage | 9.47e-04 | 21 | 64 | 2 | EFO_0022246 | |
| Disease | docosahexaenoic acid to total fatty acids percentage | 9.47e-04 | 21 | 64 | 2 | EFO_0022262 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 9.47e-04 | 200 | 64 | 4 | EFO_0004611, EFO_0020945 | |
| Disease | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | 1.06e-03 | 206 | 64 | 4 | EFO_0004612, EFO_0020947 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, lipid measurement | 1.17e-03 | 95 | 64 | 3 | EFO_0004529, EFO_0008317, EFO_0008596 | |
| Disease | chylomicron measurement, triglyceride measurement, very low density lipoprotein cholesterol measurement | 1.20e-03 | 96 | 64 | 3 | EFO_0004530, EFO_0008317, EFO_0008596 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 1.39e-03 | 222 | 64 | 4 | EFO_0008317, EFO_0020943 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 1.44e-03 | 224 | 64 | 4 | EFO_0004530, EFO_0008317 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 1.46e-03 | 225 | 64 | 4 | EFO_0008317, EFO_0020947 | |
| Disease | phospholipids:total lipids ratio | 1.51e-03 | 227 | 64 | 4 | EFO_0020946 | |
| Disease | bipolar disorder | 1.56e-03 | 577 | 64 | 6 | MONDO_0004985 | |
| Disease | gamma-glutamyltyrosine measurement | 1.57e-03 | 27 | 64 | 2 | EFO_0021144 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement | 1.60e-03 | 106 | 64 | 3 | EFO_0008317, EFO_0008596 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipid measurement | 1.73e-03 | 109 | 64 | 3 | EFO_0004639, EFO_0008317, EFO_0008596 | |
| Disease | cholesteryl ester measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 1.78e-03 | 110 | 64 | 3 | EFO_0008317, EFO_0008596, EFO_0010351 | |
| Disease | free cholesterol measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement | 1.78e-03 | 110 | 64 | 3 | EFO_0008317, EFO_0008591, EFO_0008596 | |
| Disease | chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.78e-03 | 110 | 64 | 3 | EFO_0004574, EFO_0008317, EFO_0008596 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 1.82e-03 | 239 | 64 | 4 | EFO_0008317, EFO_0020945 | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 1.94e-03 | 243 | 64 | 4 | EFO_0004612, EFO_0020944 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GYNQDSYGSSSGYSQ | 226 | Q8TBG9 | |
| SYGSSSGYSQQASLG | 231 | Q8TBG9 | |
| GYASTCNSVGQTAGY | 211 | O00400 | |
| SASSPGYQSSYQVGI | 441 | Q9P2B4 | |
| QGYGTGAYDTTTATV | 91 | Q01844 | |
| QLNSGYYVSGSSSGF | 306 | O75150 | |
| YYVSGSSSGFQGGQI | 311 | O75150 | |
| VNQSYTQGGQFYSSS | 676 | O60477 | |
| NYYGAQNTSVTTGAT | 36 | O43823 | |
| QNTSVTTGATYSYGP | 41 | O43823 | |
| LGSRYSSGYSSAEQV | 131 | Q5XKK7 | |
| ETTYTGGNGFSTSYN | 2276 | Q5JWR5 | |
| GYSQVSYSSGSGSSL | 111 | Q15517 | |
| DATNSTAGYSIYGVG | 726 | Q9H4D0 | |
| LSSYTYGGGSASSQH | 571 | O14641 | |
| NQGGYGVSSSSSSYG | 301 | Q32P51 | |
| SYGQSGGEQQSYSTY | 6 | Q92804 | |
| ASQSYSGYGQTTDSS | 31 | Q92804 | |
| SGYGQTTDSSYGQNY | 36 | Q92804 | |
| TTDSSYGQNYSGYSS | 41 | Q92804 | |
| SGYSSYGQSQSGYSQ | 51 | Q92804 | |
| SSLASYGNQPSSYGA | 336 | Q96PK6 | |
| SSYGAQAASSYGVRA | 346 | Q96PK6 | |
| GYNGTIFAYGQTSSG | 76 | P33176 | |
| SQSSGYGQYGSRETS | 551 | Q5D862 | |
| SYGQHGSGSSQSSGY | 921 | Q5D862 | |
| YRSGQSSYGQHGTGS | 1146 | Q5D862 | |
| AYGQNKTAFGTSTTG | 251 | P52948 | |
| STSNSTGQRSSYYSP | 371 | A8MTJ6 | |
| SSSLHATRTYGGSYG | 416 | P51116 | |
| TQSYIGSSRGSTIYT | 1181 | Q86Z02 | |
| QSYSGYSQSTDTSGY | 36 | P35637 | |
| YSQSTDTSGYGQSSY | 41 | P35637 | |
| DTSGYGQSSYSSYGQ | 46 | P35637 | |
| GQSSYSSYGQSQNTG | 51 | P35637 | |
| SSYGQSQNTGYGTQS | 56 | P35637 | |
| SQNTGYGTQSTPQGY | 61 | P35637 | |
| YGSSQSSQSSYGQQS | 81 | P35637 | |
| GSYGSSSQSSSYGQP | 111 | P35637 | |
| SSQSSSYGQPQSGSY | 116 | P35637 | |
| SGIGDSTHYGYSTGQ | 161 | P14415 | |
| SYGGSSYGNSTNNVP | 66 | Q6NT76 | |
| GSSFTTSSGIYTGNN | 186 | Q99502 | |
| SGQHNSYSGQSSSYG | 166 | Q86YZ3 | |
| GTYNSSGAYRFSSEG | 1126 | Q9HD67 | |
| SGGSGSGYVSSQQVT | 201 | P23490 | |
| TPSSSYGLQTSQGYT | 1931 | Q93074 | |
| LSLGSSSGSNGFYSY | 1926 | P42694 | |
| ASSYLGSTGYVGSSR | 606 | Q96M63 | |
| TQSQSGEGGSVDYSY | 346 | P52756 | |
| SYTGQDYSTQGNVGK | 256 | P49643 | |
| SSYDTGYTSQGSLGH | 151 | Q7Z6W7 | |
| TGGEGAYLYSSNLQS | 541 | Q5TEA3 | |
| GDGQSYRGTYSTTVT | 31 | P08519 | |
| NGQSYRGTYSTTVTG | 146 | P08519 | |
| GQSYRGTYSTTVTGR | 261 | P08519 | |
| YHGNGQSYRGTYSTT | 371 | P08519 | |
| HGNGQSYRGTYSTTV | 486 | P08519 | |
| GNGQSYRGTYSTTVT | 601 | P08519 | |
| NGQSYRGTYSTTVTG | 716 | P08519 | |
| GQSYRGTYSTTVTGR | 831 | P08519 | |
| GDGQSYRGSFSTTVT | 1171 | P08519 | |
| YGGYSSQTLPSQAGA | 51 | Q92796 | |
| YQTSSGQYIAITQGG | 161 | P16220 | |
| VVGNTTSGSYSYSIQ | 796 | Q9UI17 | |
| SSVSYSSTGGYTGIT | 216 | Q96A59 | |
| AGYNGTIFAYGQTSS | 76 | Q12840 | |
| ITVLTGNGDYYSSGN | 186 | O75521 | |
| TAQEYGAGTYGASST | 651 | Q92841 | |
| SNYNTVSTSMNGYGS | 481 | Q9H4W6 | |
| TSYGTQGTSFQASGY | 816 | Q9Y3R0 | |
| CTGTSSDVGGYNYVS | 41 | P01706 | |
| DYGSYSGNTQGGTST | 841 | Q9BUJ2 | |
| CTGTSSDVGGYNYVS | 41 | P01704 | |
| QASGYSQGYAGSTSY | 181 | P32243 | |
| ASGTSSSSQYLGAQG | 496 | Q96NZ1 | |
| SSLSYYSSGLQDGAG | 521 | Q75VX8 | |
| SNGHGTTQYSTFSYV | 641 | P08581 | |
| SNGQSYRGTYFTTVT | 31 | Q16609 | |
| CTGTSSDVGGYNYVS | 41 | P01709 | |
| FQTSSSYTGSGYQGG | 426 | Q8NCA5 | |
| GQVTYTGSYGISSTA | 311 | P48436 | |
| NGSLSSGMTSGYNSS | 4401 | Q9P2P6 | |
| GTSQYGHERTSQYTG | 186 | Q6UXG3 | |
| SQSGGYSDRSSGGSY | 146 | Q14011 | |
| STYSTNGQTFSLQYG | 121 | P20142 | |
| YSGGRSSSSNGYSRS | 366 | Q8N7X1 | |
| YNISTGYSGLATGNG | 96 | A7XYQ1 | |
| GSGGSTSDYVSQSYS | 161 | Q96K76 | |
| SGQSYDGSYNVNAGS | 256 | Q9UGU0 | |
| SSSRNTQGYLYTAEG | 711 | P37275 | |
| NGSQSSTYRGTYEQD | 221 | Q96N95 | |
| GQSTQSSGYSSNYAY | 141 | Q9Y5A9 | |
| TFSGSSYSNYSQGNV | 481 | Q9ULJ6 | |
| GSITSGYSQSSQVFG | 406 | P07196 | |
| GYSQSSQVFGRSAYG | 411 | P07196 |